SCHEMBL25523955

SCHEMBL25523955

CC(C)c1ncc(-c2cc(O)cc3cccnc23)cc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.43
▸ L3MBTL1 Q9Y468 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ HSP90AA1 P07900 8/20 0.40
▸ HSP90AB1 P08238 8/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ COMT P21964 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ METAP2 P50579 1/20 0.40
▸ METAP1 P53582 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ CCR1 P32246 1/20 0.38
▸ CCR5 P51681 1/20 0.38
▸ CCR8 P51685 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25523475 0.83 KDM4E (0.44) KDM4EL3MBTL1NPC1RAB9AHSP90AA1
SCHEMBL25524101 0.79 MMP2 (0.45) KDM4EL3MBTL1NPC1RAB9AHSP90AA1
SCHEMBL25521795 0.79 KDM4E (0.48) KDM4EL3MBTL1NPC1RAB9AMMP2
SCHEMBL25521931 0.77 DYRK1A (0.46) KDM4EL3MBTL1NPC1RAB9A
SCHEMBL25523899 0.75 AKR1C3 (0.42) NPC1
SCHEMBL18434758 0.74 KDM4E (0.56) KDM4EL3MBTL1NPC1RAB9AHSP90AA1
SCHEMBL25523903 0.74 KDM4E (0.40) KDM4EL3MBTL1NPC1COMTLMNA
SCHEMBL25521794 0.73 KDM4E (0.39) KDM4EL3MBTL1NPC1RAB9AHSP90AA1
SCHEMBL25521916 0.73 ERN1 (0.46) —
SCHEMBL25522060 0.72 HSP90AA1 (0.34) HSP90AA1CCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback